SCNI Scinai Immunotherapeutics Ltd.
Healthcare$0.48+4.73%ClosedMarket Cap: $635,322
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.13
P/S
0.46
EV/EBITDA
-0.19
DCF Value
$10.16
FCF Yield
-603.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
-201.8%
Operating Margin
-574.0%
Net Margin
-632.2%
ROE
-98.3%
ROA
-71.5%
ROIC
-72.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $263.6K | -524.2% | $-2.8M | $-2.1M | $— | — |
| FY null | $1.3M | -202.3% | $-7.5M | $-8.3M | $— | — |
| Q3 null | $277.3K | 0.0% | $-963.5K | $-2.1M | $— | — |
| Q2 null | $386.5K | -164.3% | $-1.9M | $-2.1M | $— | — |
| Q1 null | $386.5K | -164.3% | $-1.9M | $-2.1M | $— | — |
| Q4 null | $206.0K | -81.1% | $-2.3M | $-2.2M | $— | — |
| FY null | $658.0K | -88.1% | $-8.6M | $4.8M | $— | — |
| Q3 null | $168.0K | -148.2% | $-2.4M | $10.5M | $— | — |
| Q2 null | $284.0K | -57.7% | $4.0M | $-2.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-2.1M | $-2.2M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-1.8M | $-2.3M | $-10.40 | — |
| FY null | $0.00 | -Infinity% | $-9.7M | $-6.5M | $— | — |